Investors Overview Overview Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Corporate Factsheet Annual Reports Overview FRONT >> Quick Links Stock Info News Releases SEC Filings Analyst Coverage Presentations & Events Corporate Factsheet News Releases Jun 30 2022 Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline Jun 22 2022 Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors May 11 2022 Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update FRONT >> News > View All View All News Events May 11 2022 at 4:30 PM EDT First Quarter 2022 Financial Results Mar 28 2022 at 4:30 PM EDT Fourth Quarter 2021 Financial Results Jan 10 2022 Biotech Showcase 2022 Virtual Conference FRONT > Events - View All View All Events Featured Videos CEO Spiro Rombotis addressing Cancer Resistance Toolkit Email AlertsRSS FeedsPrint Page
Overview FRONT >> Quick Links Stock Info News Releases SEC Filings Analyst Coverage Presentations & Events Corporate Factsheet News Releases Jun 30 2022 Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline Jun 22 2022 Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors May 11 2022 Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update FRONT >> News > View All View All News Events May 11 2022 at 4:30 PM EDT First Quarter 2022 Financial Results Mar 28 2022 at 4:30 PM EDT Fourth Quarter 2021 Financial Results Jan 10 2022 Biotech Showcase 2022 Virtual Conference FRONT > Events - View All View All Events Featured Videos CEO Spiro Rombotis addressing Cancer Resistance
Jun 30 2022 Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline
Jun 22 2022 Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors
May 11 2022 Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update